cefazolin

Brand: Ancef, Kefzol

Prototype Drug
Drug Class: first-generation cephalosporin
Drug Family: antibiotic
Subclass: parenteral first-generation cephalosporin
Organ Systems: infectious-disease

Mechanism of Action

Binds PBPs to inhibit bacterial cell wall transpeptidation, causing bactericidal cell lysis. Excellent gram-positive coverage; the most commonly used parenteral first-generation cephalosporin.

penicillin-binding proteins (PBPs)

Indications

  • surgical prophylaxis
  • skin and soft tissue infections (MSSA)
  • bone and joint infections
  • uncomplicated UTI
  • group A streptococcal infections

Contraindications

  • cephalosporin hypersensitivity
  • immediate hypersensitivity to penicillin

Adverse Effects

Common

  • injection site pain
  • diarrhea
  • elevated LFTs

Serious

  • anaphylaxis
  • C. difficile colitis
  • neutropenia with prolonged use

Pharmacokinetics (ADME)

Absorption IV/IM only; IM absorption is nearly complete
Distribution widely distributed; 70–86% protein bound; poor CNS penetration
Metabolism not metabolized
Excretion renal (unchanged >80%); dose adjustment required if CrCl <10 mL/min
Half-life 1.8 hours
Onset immediate (IV)
Peak 1–2 hours (IM)
Duration 8 hours
Protein Binding 74–86%
Vd moderate

Drug Interactions

Drug / Agent Mechanism Severity
probenecid reduces renal tubular secretion, increases cefazolin exposure minor
warfarin gut flora suppression may enhance anticoagulation moderate

Nursing Considerations

  1. Administer IV over 10–60 minutes or IM into large muscle; monitor injection site.
  2. Give surgical prophylaxis dose within 30–60 minutes before incision; redose every 4 hours if surgery extends >4 hours.
  3. Reduce dose and extend interval when CrCl is <50 mL/min; monitor renal function.
  4. Assess allergy history before administration; cross-reactivity with penicillin is less than 2% for non-anaphylactic history.

Clinical Pearls

  • Cefazolin is the drug of choice for surgical prophylaxis for most clean and clean-contaminated surgeries due to its narrow spectrum, safety profile, and low cost.
  • Despite being an older drug, cefazolin remains a first-line agent for MSSA bacteremia, showing non-inferiority to antistaphylococcal penicillins in major trials.

Safety Profile

Pregnancy generally-safe
Lactation use-with-caution
Renal Adjustment Required
Hepatic Adjustment Not required
TDM Not required